FCG/YCP Webinar Series

Neil Strotman

Merck Sharp & Dohme (MSD) - Tuesday 28 July

Neil Strotman is a Director of Chemistry in the Enabling Technologies group within Process Research in Merck Research Laboratories, situated in Rahway, NJ, USA. He received his doctoral training in physical organic/organometallic chemistry at the University of Wisconsin-Madison with Prof. Chuck Casey, before studying nickel mediated cross couplings as a post-doctoral fellow with Prof. Greg Fu at MIT.
Since joining the pharmaceutical industry in 2007, Neil has held various roles at Merck and BMS in catalysis, discovery process chemistry, reaction sciences and engineering, flow chemistry, and process chemistry. In his current role, Neil is the director of the Catalysis Group, Labeled Compound Synthesis Group, and Particle Engineering Lab within Process R&D. He is the author of 30+ publications, and in his free time enjoys traveling with his family and woodworking.

Ania Fryszkowska

Merck Sharp & Dohme (MSD) - Tuesday 28 July

Ania Fryszkowska is a Principal Scientist in the group of Enabling Technologies at Merck Research Laboratories (USA). She received her doctoral training in organic chemistry at Warsaw University of Technology (Poland), followed by postdoctoral training with Nigel Scrutton at Manchester Institute of Biotechnology (UK), where she applied enzymatic transformations in stereoselective synthesis of small molecules.

Since her transition to the pharmaceutical industry in 2010, Ania's research focuses on the application of diverse biocatalytic transformations in the discovery and manufacture of therapeutics. In her most recent work, she has been combining the power of directed evolution and enzymatic cascades to construct the structural complexity of non-natural molecules, such as nucleoside analogs. She is the author of 20+scientific publications and 10 patent applications.